Company intelligence / Profile preview

MINO Labs

Mexico City, CDMX, Mexicominolabs.com ↗

Ownership: Private
Development stage: Commercial

Overview

MINO Labs is an established Mexican pharmaceutical company specializing in the commercialization of innovative health and wellness products. It leverages over two decades of experience to bring both proprietary and partnered therapies—especially for dermatological conditions—to market across Mexico and Latin America. The company has strong regulatory, marketing, logistics, and sales infrastructure.

Therapeutic areas: OtherDermatology
Modalities: OTC productsRx pharmaceuticalsBiological productsMedical devices for dermatology (via partnerships)
Industry: Therapeutic Medical Devices

Drug pipeline

1 asset

Canna XR

Commercial

Indications: Dermatology

Partnerships

Stratpharma (Switzerland)Roha Arzneimittel (Germany)DivaCup (Canada)Neomedis (France)STRATA Skin Sciences Inc.

Beyond the preview

Go deeper on MINO Labs.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MINO Labs.

Explore the full profile